AU6362594A - Hyaluronic acid used as a cancer treatment - Google Patents

Hyaluronic acid used as a cancer treatment

Info

Publication number
AU6362594A
AU6362594A AU63625/94A AU6362594A AU6362594A AU 6362594 A AU6362594 A AU 6362594A AU 63625/94 A AU63625/94 A AU 63625/94A AU 6362594 A AU6362594 A AU 6362594A AU 6362594 A AU6362594 A AU 6362594A
Authority
AU
Australia
Prior art keywords
hyaluronic acid
cancer treatment
acid used
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63625/94A
Inventor
Karen K. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of AU6362594A publication Critical patent/AU6362594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63625/94A 1993-03-10 1994-03-08 Hyaluronic acid used as a cancer treatment Abandoned AU6362594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2895793A 1993-03-10 1993-03-10
US028957 1993-03-10
PCT/US1994/002506 WO1994020115A2 (en) 1993-03-10 1994-03-08 Hyaluronic acid used as a cancer treatment

Publications (1)

Publication Number Publication Date
AU6362594A true AU6362594A (en) 1994-09-26

Family

ID=21846439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63625/94A Abandoned AU6362594A (en) 1993-03-10 1994-03-08 Hyaluronic acid used as a cancer treatment

Country Status (2)

Country Link
AU (1) AU6362594A (en)
WO (1) WO1994020115A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902795A (en) * 1992-06-16 1999-05-11 Trustees Of Tufts College Oligosaccharides reactive with hyaluronan-binding protein and their methods of use
US6114161A (en) * 1995-01-30 2000-09-05 Lunamed Ag Antitumor preparations
JPH09163896A (en) * 1995-12-13 1997-06-24 Sumitomo Pharmaceut Co Ltd Model animal of pleuritic morbid state
CA2175282A1 (en) * 1996-04-29 1997-10-30 Rudolf Edgar Falk Use of forms of hyaluronic acid (ha) for the treatment of cancer
AU784356B2 (en) * 1999-12-28 2006-03-16 Bioniche Urology Ip Inc. Hyaluronic acid in the treatment of cancer
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
CA2664158C (en) * 2006-09-22 2015-11-24 Kochi University Radiation sensitizer or anti-cancer chemotherapy sensitizer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
JPS6117A (en) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd Mucopolysaccharide-type cancer-metastatis suppressing agent
US4725585A (en) * 1985-04-26 1988-02-16 Pharmacia Ab Method of enhancing the host defense
FR2584606A1 (en) * 1985-07-12 1987-01-16 Dropic USE OF POLY- AND OLIGOSACCHARIDES FOR THE PRODUCTION OF ACTIVE MEDICAMENTS IN THE PATHOLOGIES OF CONNECTIVE TISSUE
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME
JP2667441B2 (en) * 1988-05-18 1997-10-27 生化学工業株式会社 Vascular endothelial cell growth inhibitor

Also Published As

Publication number Publication date
WO1994020115A2 (en) 1994-09-15
WO1994020115A3 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
AU6212094A (en) Anti-stall tip treatment means
AU696232B2 (en) Syringe
AU6623894A (en) Therapeutic compounds
AU8102794A (en) Connector
AU5975694A (en) Electrotherapeutic apparatus
AU3888793A (en) Novel medicament
AU7085594A (en) Syringe
AU5389194A (en) Wastewater treatment
AU7961094A (en) Picosulphate dosage form
AU680953B2 (en) Connectors
AU667757B2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives
AU6092794A (en) Oxime-substituted therapeutic compounds
AU7747594A (en) Connector
AU7930394A (en) Pyrimidinyl-glutamic acid derivatives
AU1480497A (en) Cancer treatment
AU1278295A (en) Wastewater treatment
AU5287293A (en) Bending stiffener
AU6362594A (en) Hyaluronic acid used as a cancer treatment
AU5758894A (en) Acyloxyhexanoic acid derivatives
AU7072794A (en) 2-oximino-2-thienyl-acetic acid derivatives
AU7820794A (en) Catheter
AU5165993A (en) Pp14-based therapy
AU1191895A (en) Il-6 therapy
AU7789994A (en) Flocculants
AU6169294A (en) 15-oxasterols as hypocholesterolemics